Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

Products

Therapeutic Areas

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and Central Nervous System (CNS) disorders, including ADHD. Each of these areas is supported by a dedicated, national sale force organized under and managed by our specialty pharmaceutical subsidiary, Noven Therapeutics (NT). The NT-Women’s Health unit supports Brisdelle® (paroxetine 7.5 mg capsules), Minivelle® (estradiol transdermal system) and CombiPatch® (estradiol/norethindrone acetate transdermal system) products. The NT-CNS unit supports our Daytrana® (methylphenidate transdermal system), Pexeva® (paroxetine mesylate); Stavzor® (valproic acid delayed release capsules); and Lithobid® (lithium carbonate) products.

For additional information on our therapeutic areas of focus and related products, click on the tabs above.

More Information

Brisdelle® and Minivelle®
Patient, Physician
and Pharmacist Inquiries:

INC Research, LLC
441 Vine Street
Suite1200
Cincinnati, OH 45202
Att: Safety Department
Tel: 800-455-8070

Daytrana® Patient, Physician
and Pharmacist Inquiries:

INC Research, LLC
441 Vine Street
Suite1200
Cincinnati, OH 45202
Att: Safety Department
Tel: 877-567-7857

Stavzor®, Pexeva®, and Lithobid® Patient, Physician
and Pharmacist Inquiries:

INC Research, LLC
441 Vine Street
Suite1200
Cincinnati, OH 45202
Att: Safety Department
Tel: 800-455-8070

Vivelle-Dot® or CombiPatch® Patient, Physician
and Pharmacist Inquiries:

Customer Interaction Center Novartis Pharmaceuticals Corporation
One Health Plaza
Building 122
East Hanover, NJ 07936
Tel: 888-669-6682
Fax: 973-781-3115
Click here for E-mail Contact